Cargando…
Inhibition of CYP3A-mediated Midazolam Metabolism by Kaempferia Parviflora
Kaempferia parviflora (KP) extract has recently attracted attention in Japan as a dietary supplement; however, there is little information regarding food-drug interactions (FDIs). The current study was conducted to clarify the FDI of KP extract via inhibition of cytochrome P450 3A (CYP3A), a typical...
Autores principales: | Kashiwabuchi, Yumika, Nishimura, Yuki, Kurata, Norimitsu, Iwase, Mariko, Kiuchi, Yuji, Nobe, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Food Safety Commission, Cabinet Office, Government of Japan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008879/ https://www.ncbi.nlm.nih.gov/pubmed/35510070 http://dx.doi.org/10.14252/foodsafetyfscj.D-21-00013 |
Ejemplares similares
-
Antiobesity effect of Kaempferia parviflora accompanied by inhibition of lipogenesis and stimulation of lipolysis
por: Park, Seong-Hoo, et al.
Publicado: (2023) -
Suppression of benign prostate hyperplasia by Kaempferia parviflora rhizome
por: Murata, Kazuya, et al.
Publicado: (2013) -
Kaempferia parviflora and Its Methoxyflavones: Chemistry and Biological Activities
por: Chen, Dalin, et al.
Publicado: (2018) -
Clinical Effects of Krachaidum (Kaempferia parviflora): A Systematic Review
por: Saokaew, Surasak, et al.
Publicado: (2016) -
Characterizing Kaempferia parviflora extracellular vesicles, a nanomedicine candidate
por: Nemidkanam, Variya, et al.
Publicado: (2022)